ERAP2 Therapy(Grey Wolf Therapeutics)

N/A

Report date: 2024/06/07 14:41:21
NME

Base Information

Drug NameERAP2 Therapy(Grey Wolf Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndoplasmic Reticulum Aminopeptidase 2 modulators
TargetsEndoplasmic Reticulum Aminopeptidase 2
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGrey Wolf Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGrey Wolf Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A